vldl triglyceride
Recently Published Documents


TOTAL DOCUMENTS

103
(FIVE YEARS 1)

H-INDEX

30
(FIVE YEARS 0)

Nutrients ◽  
2021 ◽  
Vol 13 (4) ◽  
pp. 1224
Author(s):  
Ewa Wieczorek ◽  
Agnieszka Ćwiklińska ◽  
Agnieszka Kuchta ◽  
Barbara Kortas-Stempak ◽  
Anna Gliwińska ◽  
...  

Impaired triglyceride-rich lipoprotein plasma catabolism is considered the most important factor for hypertriglyceridemia development. The aim of this study was to evaluate the impact of hypercholesterolemia and hypertriglyceridemia on the efficiency of lipoprotein lipase (LPL)-mediated very-low-density lipoprotein (VLDL)-triglyceride lipolysis and the role of high-density lipoprotein (HDL) in this process. Subjects with no history of cardiovascular disease (CVD) and untreated with lipid-lowering agents were recruited into the study and divided into normolipidemic, hypercholesterolemic, and hyperlipidemic groups. VLDL was isolated from serum and incubated with LPL in the absence or presence of HDL. For the hypercholesterolemic and hyperlipidemic groups, a significantly lower percentage of hydrolyzed VLDL-triglyceride was achieved compared to the normolipidemic group (p < 0.01). HDL enhanced the lipolysis efficiency in the hypercholesterolemic and hyperlipidemic groups on average by ~7% (p < 0.001). The lowest electrophoretic mobility of the VLDL remnants indicating the most effective lipolysis was obtained in the normolipidemic group (p < 0.05). HDL presence significantly reduced the electrophoretic mobility of the VLDL remnants for the hypercholesterolemic and hyperlipidemic groups (p < 0.05). The results of our study indicate that VLDL obtained from hypercholesterolemic and hyperlipidemic subjects are more resistant to lipolysis and are additional evidence of the need for early implementation of hypocholesterolemic treatment, already in asymptomatic CVD subjects.


2020 ◽  
Vol 105 (10) ◽  
pp. 3152-3164
Author(s):  
Véronique Ferchaud-Roucher ◽  
Yassine Zair ◽  
Audrey Aguesse ◽  
Michel Krempf ◽  
Khadija Ouguerram

Abstract Context Evidence for an association between sphingolipids and metabolic disorders is increasingly reported. Omega-3 long-chain polyunsaturated fatty acids (n-3 LC-PUFAs) improve apolipoprotein B100 (apoB100)-containing lipoprotein metabolism, but their effects on the sphingolipid content in lipoproteins remain unknown. Objectives In subjects with hypertriglyceridemia, we analyzed the effect of n-3 LC-PUFAs on the turnover apoB100-containing lipoproteins and on their sphingolipid content and looked for the possible association between these lipid levels and apoB100-containing lipoprotein turnover parameters. Methods Six subjects underwent a kinetic study before and after n-3 supplementation for 2 months with 1 g of fish oil 3 times day containing 360 mg of eicosapentaenoic acid (EPA) and 240 mg of docosahexaenoic acid (DHA) in the form of triglycerides. We examined apoB100-containing lipoprotein turnover by primed perfusion labeled [5,5,5-2H3]-leucine and determined kinetic parameters using a multicompartmental model. We quantified sphingolipid species content in lipoproteins using mass spectrometry. Results Supplementation decreased very low-density lipoprotein (VLDL), triglyceride, and apoB100 concentrations. The VLDL neutral and polar lipids showed increased n-3 LC-PUFA and decreased n-6 LC-PUFA content. The conversion rate of VLDL1 to VLDL2 and of VLDL2 to LDL was increased. We measured a decrease in total apoB100 production and VLDL1 production. Supplementation reduced the total ceramide concentration in VLDL while the sphingomyelin content in LDL was increased. We found positive correlations between plasma palmitic acid and VLDL ceramide and between VLDL triglyceride and VLDL ceramide, and inverse correlations between VLDL n-3 LC-PUFA and VLDL production. Conclusion Based on these results, we hypothesize that the improvement in apoB100 metabolism during n-3 LC-PUFA supplementation is contributed to by changes in sphingolipids


Metabolism ◽  
2020 ◽  
Vol 103 ◽  
pp. 154029 ◽  
Author(s):  
Yang Li ◽  
Mingyuan Tian ◽  
Mengliu Yang ◽  
Gangyi Yang ◽  
Jianrong Chen ◽  
...  

2019 ◽  
Vol 104 (12) ◽  
pp. 6171-6181 ◽  
Author(s):  
Kelli A Lytle ◽  
Nikki C Bush ◽  
Jessica M Triay ◽  
Todd A Kellogg ◽  
Michael L Kendrick ◽  
...  

Abstract Objective Nonalcoholic fatty liver disease can lead to hepatic inflammation/damage. Understanding the physiological mechanisms that contribute to excess hepatic lipid accumulation may help identify effective treatments. Design We recruited 25 nondiabetic patients with severe obesity scheduled for bariatric surgery. To evaluate liver export of triglyceride fatty acids, we measured very-low-density lipoprotein (VLDL)–triglyceride secretion rates the day prior to surgery using an infusion of autologous [1-14C]triolein-labeled VLDL particles. Ketone body response to fasting and intrahepatic long-chain acylcarnitine concentrations were used as indices of hepatic fatty acid oxidation. We measured intraoperative hepatic uptake rates of plasma free fatty acids using a continuous infusion of [U-13C]palmitate, combined with a bolus dose of [9,10-3H]palmitate and carefully timed liver biopsies. Total intrahepatic lipids were measured in liver biopsy samples to determine fatty liver status. The hepatic concentrations and enrichment from [U-13C]palmitate in diacylglycerols, sphingolipids, and acyl-carnitines were measured using liquid chromatography/tandem mass spectrometry. Results Among study participants with fatty liver disease, intrahepatic lipid was negatively correlated with VLDL-triglyceride secretion rates (r = −0.92, P = 0.01) but unrelated to hepatic free fatty acid uptake or indices of hepatic fatty acid oxidation. VLDL-triglyceride secretion rates were positively correlated with hepatic concentrations of saturated diacylglycerol (r = 0.46, P = 0.02) and sphingosine-1-phosphate (r = 0.44, P = 0.03). Conclusion We conclude that in nondiabetic humans with severe obesity, excess intrahepatic lipid is associated with limited export of triglyceride in VLDL particles rather than increased uptake of systemic free fatty acids.


JCI Insight ◽  
2018 ◽  
Vol 3 (21) ◽  
Author(s):  
J. Humberto Treviño-Villarreal ◽  
Justin S. Reynolds ◽  
Alexander Bartelt ◽  
P. Kent Langston ◽  
Michael R. MacArthur ◽  
...  

2016 ◽  
Vol 101 (11) ◽  
pp. 4151-4160 ◽  
Author(s):  
Bettina Mittendorfer ◽  
Mihoko Yoshino ◽  
Bruce W. Patterson ◽  
Samuel Klein

2016 ◽  
Vol 101 (4) ◽  
pp. 1637-1646 ◽  
Author(s):  
Marianne K. Poulsen ◽  
Birgitte Nellemann ◽  
Hans Stødkilde-Jørgensen ◽  
Steen B. Pedersen ◽  
Henning Grønbæk ◽  
...  

2015 ◽  
Vol 56 (7) ◽  
pp. 1296-1307 ◽  
Author(s):  
Yan Wang ◽  
Viktoria Gusarova ◽  
Serena Banfi ◽  
Jesper Gromada ◽  
Jonathan C. Cohen ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document